Portfolio company
Promakhos
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops oral small-molecule immunotherapies that restore immune system function to treat patients with chronic inflammatory diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Promakhos Therapeutics
This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.
Forward Therapeutics
The company develops oral small-molecule medicines for patients with chronic immunological and inflammatory disorders.
PsiThera
PsiThera develops oral small-molecule medicines for patients with immune and inflammatory diseases, using a physics-driven platform to target proteins traditionally requiring injections.
Odyssey Therapeutics
This biopharmaceutical company develops oral small molecule and protein medicines for patients with autoimmune and inflammatory diseases.
Sitryx Therapeutics
The company develops oral small molecule therapies to treat patients with autoimmune and inflammatory diseases by regulating immune cell metabolism.
Immunic Therapeutics
The company develops oral therapies for chronic inflammatory and autoimmune diseases for patients with neurological and gastrointestinal conditions.
Sitryx
This biopharmaceutical company develops oral small molecule medicines that target immune cell metabolism to treat patients with chronic autoimmune and inflammatory diseases.
Evommune
This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.